Loading...
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
BACKGROUND: Allogeneic stem cell transplantation from haploidentical donor using an unmanipulated graft and post-transplantation cyclophosphamide (PT-Cy) is growing. Haploidentical transplantation with PT-Cy showed a major activity in Hodgkin lymphoma (HL), reducing the relapse incidence. The most i...
Saved in:
Published in: | BMC Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BioMed Central
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685618/ https://ncbi.nlm.nih.gov/pubmed/33234127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07602-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|